Ibogaine May Aid Mild Traumatic Brain Injury in Veterans

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 11, 2024.

By Lori Solomon HealthDay Reporter

THURSDAY, Jan. 11, 2024 -- A single treatment of oral ibogaine may improve chronic disability and mental health related to repeated mild traumatic brain injury (TBI) from combat/blast exposures, according to a study published online Jan. 5 in Nature Medicine.

Kirsten N. Cherian, Ph.D., from the Brain Stimulation Lab at the Stanford University School of Medicine in California, and colleagues assessed changes in disability and mental health among 30 male special operations force veterans with predominantly mild TBI (repeated blast/combat exposures) from baseline to immediately (primary outcome) and one month (secondary outcome) after treatment with oral ibogaine.

The researchers found that Magnesium–Ibogaine: the Stanford Traumatic Injury to the Central Nervous System protocol resulted in significant improvements in functioning both immediately and one month after treatment. Improvements were also seen for posttraumatic stress disorder, depression, and anxiety at one month after treatment. No unexpected or serious adverse events occurred.

"The study was not controlled and so the relative contribution of any therapeutic benefits from nonibogaine elements of the experience, such as complementary treatments, group activities, coaching, international travel, expectancy, or other nonspecific effects, cannot be determined," the authors write.

Several authors disclosed ties to industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords